High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
Vimalachandran D, Greenhalf W, Thompson C, Lüttges J, Prime W, Campbell F, Dodson A, Watson R, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos J, Costello E.
Vimalachandran D, et al. Among authors: costello e.
Cancer Res. 2005 Apr 15;65(8):3218-25. doi: 10.1158/0008-5472.CAN-04-4311.
Cancer Res. 2005.
PMID: 15833853